Wrn Protein Werner Syndrome Recq Like Helicase is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| Protein Name | Werner Syndrome RecQ Like Helicase |
|---|
| Gene | [WRN](/genes/wrn) |
|---|
| UniProt ID | Q9H2L9 |
|---|
| PDB ID | 2JXK, 2JXF, 4WZD |
|---|
| Molecular Weight | 164 kDa |
|---|
| Subcellular Localization | Nucleus, nucleolus |
|---|
| Protein Family | RecQ helicase family |
|---|
WRN is the protein product of the Werner syndrome gene (WRN), a member of the RecQ family of DNA helicases. WRN is unique among RecQ helicases in possessing both 3'→5' helicase and 3'→5' exonuclease activities. This bifunctionality allows WRN to process diverse DNA structures encountered during DNA replication, repair, and recombination. WRN is essential for maintaining genomic integrity, and its dysfunction causes the premature aging disorder Werner syndrome.
¶ Domain Architecture
WRN contains multiple functional domains:
- N-terminal exonuclease domain: 3'→5' exonuclease activity
- RecQ helicase domain: 3'→5' helicase activity
- RQC domain: RecQ helicase conserved region
- HRDC domain: Helicase RNase D C-terminal
- NLS: Nuclear localization signal
- Only human RecQ helicase with exonuclease activity
- DNA binding domains for various DNA structures
- Protein interaction domains for repair factors
- 3'→5' helicase: Unwinds duplex DNA, forked structures, D-loops
- 3'→5' exonuclease: Degrades DNA from 3' ends
- DNA strand annealing: Promotes DNA reannealing
- Base excision repair (BER): Processes oxidative lesions
- Homologous recombination: Resolves recombination intermediates
- Telomere maintenance: Prevents telomere dysfunction
- Replication restart: Resolves stalled forks
- Highest in neural stem cells
- Moderate in mature neurons
- Declines with age
Biallelic WRN mutations cause:
- Premature aging beginning in adolescence
- Short stature, graying, cataracts
- Type 2 diabetes, osteoporosis
- Cancer predisposition
- Accelerated neurodegeneration
- Reduced WRN expression in AD brain
- Accumulation of oxidative DNA damage
- Telomere shortening in neurons
- Interaction with tau pathology
- Mitochondrial DNA repair deficiency
- WRN may translocate to damaged mitochondria
- WRN expression declines with age
- Somatic mutations accumulate
- Contributes to age-related genomic instability
Patients with WS exhibit premature aging beginning in adolescence:
- Growth Deficiency: Short stature due to growth plate closure
- Premature Aging: Gray hair, hair loss, cataracts, type 2 diabetes
- Cancer Predisposition: High risk of sarcomas, meningiomas, thyroid carcinoma
- Neurological Symptoms: Progressive neurodegeneration, dementia, parkinsonism
The WRN helicase functions in:
- Replication Fork Stabilization: Prevents fork collapse at DNA damage sites
- Telomere Maintenance: Manages telomere length and integrity
- Transcription Regulation: Facilitates RNA polymerase II processivity
- DNA Repair Coordination: Links base excision repair to cell cycle checkpoints
No cure exists for WS, but research focuses on:
- Telomere Lengthening: TA-65 (astragaloside IV) and other telomerase activators
- DNA Repair Enhancement: Small molecules enhancing WRN activity
- Senolytic Drugs: Eliminating senescent cells that accumulate in WS
- Gene Therapy: Viral vector delivery of functional WRN gene
The study of Wrn Protein Werner Syndrome Recq Like Helicase has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
[1] Croteau DL, et al. Nat Rev Mol Cell Biol. 2014;15(11):717-728. PMID:25274485
[2] Oshima J, et al. Nat Rev Cancer. 2017;17(4):262-275. PMID:28272588
[3] Bohr VA. J Mol Med (Berl). 2005;83(10):795-802. PMID:16001326
[4] Katyal S, et al. Nat Rev Neurol. 2014;10(12):687-694. PMID:25366156
[5] Lebel M, et al. Trends Neurosci. 2006;29(10):587-595. PMID:16890452